Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-13-018375
Filing Date
2013-12-20
Accepted
2013-12-20 16:20:50
Documents
2
Period of Report
2013-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2278
2 ex24bernitz.txt EX-24 3956
  Complete submission text file 0001179110-13-018375.txt   7461
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COLEY PHARMACEUTICAL GROUP, INC. 93 WORCESTER STREET, SUITE 101 WELLESLEY MA 02481
Business Address
Bernitz Steven B (Reporting) CIK: 0001335334 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 131291795